Hovid likely to offset capacity loss


Mitigating factor: Workers packing and labelling bottles containing pharmaceutical products at Hovid’s plant in Chemor which contributes 70 of company’s total capacity.

CIMB Research: Chemor plant resumption good news

PETALING JAYA: Although Hovid Bhd’s Ipoh plant is still suspended from operations, the resumption of production at its Chemor plant bodes well for the Perak-based healthcare and pharmaceutical company, which had the manufacturing licences of both the plants revoked in January.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Hovid

   

Next In Business News

Ringgit opens higher against US$, other major currencies
KLK's recruitment issues to be short-lived, say analysts
Renewed bets on Fed cuts boost KLCI to 1,600
Wall Street closes higher for third session on rate cut optimism
Trading ideas: Ho Hup, Favelle, KKB, Nice, Sunzen Biotech, Sin-Kung, Ireka, Malaysian Genomics, RHB, Seng Fong
RBA to maintain key rate to restrain price pressures
The Global South and the need for economic growth
Optus names Stephen Rue as new chief executive
ADB gets highest net income allocation in history
Century-old association continues moving with the times

Others Also Read